Hydroxocobalamin Injection Recalled for Lack of Sterility Assurance
Vita Pharmacy, LLC dba Talon Compounding Pharmacy is recalling Hydroxocobalamin 1,000 MCG/mL injectable vials due to lack of assurance of sterility. The affected lot was distributed across the United States, including Washington, D.C. and Puerto Rico.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: This is an FDA Class II recall of an injectable drug with a critical safety defect (lack of sterility assurance), which can lead to serious infections and potentially require hospitalization. Class II recalls of injectable pharmaceuticals meet the Severe threshold even without reported illnesses to date.
Plain-English summary
Vita Pharmacy, LLC dba Talon Compounding Pharmacy is recalling Hydroxocobalamin 1,000 MCG/mL Injectable, supplied in 1,000 MCG/mL vials, due to lack of assurance of sterility.
The recalled product is lot 09102021:19 with a beyond-use date of 11/09/2021. The product was distributed across the United States, including Washington, D.C. and Puerto Rico.
Consumers who have received this medication should contact their healthcare provider for guidance. Healthcare providers who dispensed this product should review their records to identify affected patients and take appropriate action.
The recalled product
- Product
- HYDROXOCOBALAMIN 1,000MCG/ML INJ VIAL 1,000MCG/ML INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
- Manufacturer
- Vita Pharmacy, LLC dba Talon Compounding Pharmacy
- Category
- Drug — Injectable / Compounded
- Hazard
- lack-of-sterility
- contamination-risk
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lot: 09102021:19 BUD: 11/09/2021
Distribution
Distribution scope not specified by the agency.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- ModerateGas-X Simethicone 125 mg softgels recall for incomplete labeling
FDA (Drugs) · 2026-05-27
- ModerateVitamin B-Complex, Vitamin C & Folic Acid Dietary Supplement Oral Liquid
FDA (Drugs) · 2026-05-27